As new psychoactive substances (NPS) flood the market and “designer drug” sales are on the rise, we are faced with significant – and growing – social and analytical challenges. Here, I offer an overview of a quietly unraveling crisis.Non peer reviewedFinal Accepted Versio
Continued diversification and use of new psychoactive substances (NPS) across Europe remains a publi...
The use of novel psychoactive substances (NPS) or ‘legal highs’ is an emerging issue worldwide. Ther...
This is the peer reviewed version of the following article: Corazza O., Parrott A. C., Demetrovics Z...
In parallel with a decrease/stabilization in the use of internationally controlled drugs, the market...
This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions f...
© 2018 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article dist...
New psychoactive substances are the newest danger trending on the drug market. Though they are defin...
Over the last few years, hundreds of new psychoactive substances (NPS) have been identified in Europ...
This chapter provides an overview of the varied definitions of New Psychoactive Substances (NPS) or ...
© 2020 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article dist...
During the last few years, the rapid emergence of novel psychoactive substances (NPS) has signifi...
New psychoactive substances (NPSs), sometimes referred to as “legal highs” in more colloquial enviro...
Novel psychoactive substances (NPS) have been a part of the landscape of clinical and forensic toxic...
There has been growing clinical, public, and media awareness and concern about the availability and ...
Summary • All the available official data indicates that in general terms, albeit with some recent ...
Continued diversification and use of new psychoactive substances (NPS) across Europe remains a publi...
The use of novel psychoactive substances (NPS) or ‘legal highs’ is an emerging issue worldwide. Ther...
This is the peer reviewed version of the following article: Corazza O., Parrott A. C., Demetrovics Z...
In parallel with a decrease/stabilization in the use of internationally controlled drugs, the market...
This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions f...
© 2018 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article dist...
New psychoactive substances are the newest danger trending on the drug market. Though they are defin...
Over the last few years, hundreds of new psychoactive substances (NPS) have been identified in Europ...
This chapter provides an overview of the varied definitions of New Psychoactive Substances (NPS) or ...
© 2020 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article dist...
During the last few years, the rapid emergence of novel psychoactive substances (NPS) has signifi...
New psychoactive substances (NPSs), sometimes referred to as “legal highs” in more colloquial enviro...
Novel psychoactive substances (NPS) have been a part of the landscape of clinical and forensic toxic...
There has been growing clinical, public, and media awareness and concern about the availability and ...
Summary • All the available official data indicates that in general terms, albeit with some recent ...
Continued diversification and use of new psychoactive substances (NPS) across Europe remains a publi...
The use of novel psychoactive substances (NPS) or ‘legal highs’ is an emerging issue worldwide. Ther...
This is the peer reviewed version of the following article: Corazza O., Parrott A. C., Demetrovics Z...